Page last updated: 2024-08-22

diacerein and Chemical and Drug Induced Liver Injury, Chronic

diacerein has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jin, L; Li, G; Liang, G; Liang, S; Luo, W; Sun, J; Wang, M; Wang, Y; Yu, T1

Other Studies

1 other study(ies) available for diacerein and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
Diacerein protects liver against APAP-induced injury via targeting JNK and inhibiting JNK-mediated oxidative stress and apoptosis.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 149

    Topics: Acetaminophen; Animals; Anthraquinones; Apoptosis; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Hepatocytes; JNK Mitogen-Activated Protein Kinases; Liver; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Oxidative Stress; RNA

2022